Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07940517
NA

PECS II Block Versus Intravenous Lidocaine for Analgesia in Breast Surgery

Sponsor: Istanbul Medeniyet University

View on ClinicalTrials.gov

Summary

The goal of this clinical trial was to compare two methods of pain control in adults having breast-conserving surgery. The study compared a chest wall nerve block called a PECS II block with lidocaine given through a vein during surgery. The main question it aimed to answer was: • Does a PECS II block lower the amount of opioid pain medicine needed during the first 12 hours after surgery compared with intravenous lidocaine? The study also looked at pain scores after surgery and the amount of remifentanil needed during surgery. Researchers compared participants who received a PECS II block before surgery with participants who received intravenous lidocaine during surgery. Participants: * Received either a PECS II block before surgery or intravenous lidocaine during surgery * Had their pain scores and pain medicine use recorded for up to 12 hours after surgery

Official title: Comparison of the Analgesic Efficacy of Ultrasound-Guided Type-2 Pectoral Nerve Block and Intravenous Lidocaine Infusion in Breast Surgery

Key Details

Gender

FEMALE

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

66

Start Date

2023-11-01

Completion Date

2024-01-27

Last Updated

2026-11-17

Healthy Volunteers

No

Interventions

PROCEDURE

Ultrasound-Guided PECS II Block

An ultrasound-guided PECS II block was performed at least 30 minutes before surgery. A total of 20 mL of 0.25% bupivacaine was injected between the pectoralis minor and serratus anterior muscles, followed by 10 mL of 0.25% bupivacaine between the pectoralis major and pectoralis minor muscles.

DRUG

Lidocaine (without epinephrine)

lidocaine was administered intravenously immediately before the surgical incision as a 1.5 mg/kg bolus, followed by a continuous intraoperative infusion of 2 mg/kg/hour until the end of surgery.

Locations (1)

Istanbul Medeniyet University Prof. Dr. Süleyman Yalçın City Hospital

Istanbul, Turkey (Türkiye)